IDEXX Laboratories, Inc. (LON:0J8P)
607.08
-22.75 (-3.61%)
At close: Oct 1, 2025
IDEXX Laboratories Employees
IDEXX Laboratories had 11,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
267.92K GBP
Profits / Employee
65.40K GBP
Market Cap
37.47B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11,000 | 0 | - |
Dec 31, 2023 | 11,000 | 220 | 2.04% |
Dec 31, 2022 | 10,780 | 430 | 4.15% |
Dec 31, 2021 | 10,350 | 1,050 | 11.29% |
Dec 31, 2020 | 9,300 | 100 | 1.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Genus | 3,500 |
IDEXX Laboratories News
- 17 days ago - Here's How Much $100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today - Benzinga
- 19 days ago - IDXX Quantitative Stock Analysis - Nasdaq
- 26 days ago - IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - IDEXX Laboratories Inc (IDXX) to Participate in Morgan Stanley Global Healthcare Conference | ... - GuruFocus
- 4 weeks ago - IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference - Business Wire
- 5 weeks ago - Options Exercise: M. Anne Szostak At IDEXX Laboratories Realizes $951K - Benzinga
- 7 weeks ago - Insider Selling: Michael G Erickson Unloads $263K Of IDEXX Laboratories Stock - Benzinga
- 7 weeks ago - $1000 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth This Much Today - Benzinga